Lack of GS in TAMs strongly favors histocompatibility complex class II (MHC-II)high and CD206low M1-like phenotype with an improved quantity of anti-tumor CD8 T cells (Palmieri et al., 2017). This evidence concerns the gene CD8A and neoplasm.